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Objectives This study sought to determine the efﬁcacy of patient pelvic lead shielding for the re-
duction of operator radiation exposure during cardiac catheterization via the radial access in com-
parison with the femoral access.
Background Cardiac catheterization via the radial access is associated with signiﬁcantly increased
radiation dose to the patient and the operator. Improvements in radiation protection are needed to
minimize this drawback. Pelvic lead shielding has the potential to reduce operator radiation dose.
Methods We randomly assigned 210 patients undergoing elective coronary angiography by the
same operator to a radial and femoral access with and without pelvic lead shielding of the patient.
Operator radiation dose was measured by a radiation dosimeter attached to the outside breast
pocket of the lead apron.
Results For radial access, operator dose decreased from 20.9  13.8 Sv to 9.0  5.4 Sv, p 
.0001 with pelvic lead shielding. For femoral access, it decreased from 15.3  10.4 Sv to 2.9 
.7 Sv, p  0.0001. Pelvic lead shielding signiﬁcantly decreased the dose-area product–normalized
perator dose (operator dose divided by the dose-area product) by the same amount for radial and
emoral access (0.94  0.28 to 0.39  0.19 Sv  Gy1  cm2 and 0.70  0.26 to 0.16  0.13
Sv  Gy1  cm2, respectively).
Conclusions Pelvic lead shielding is highly effective in reducing operator radiation exposure for
radial as well as femoral procedures. However, despite its use, radial access remains associated with
a higher operator radiation dose. (J Am Coll Cardiol Intv 2012;5:445–9) © 2012 by the American
College of Cardiology Foundation
From the *Kardiologisch-Angiologische Praxis Herzzentrum Bremen, Bremen, Germany; and the †Institute for Radiology and
Academy for Radiation Protection, Klinikum Links der Weser, Bremen, Germany. Both authors have reported that they have no
relationships relevant to the contents of this paper to disclose.Manuscript received September 14, 2011; revised manuscript received December 13, 2011, accepted December 22, 2011.
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446Radial access is gaining increasing acceptance in catheter-
ization laboratories because of its lower vascular complica-
tion rate, less patient discomfort, and lower cost (1–5).
Higher operator radiation exposure has been recognized as
a drawback contributing to the skepticism held by many
interventional cardiologists against the transradial route
(6–9). Despite the efficacy of conventional lead aprons in
blocking nearly 95% of scatter radiation to the body,
radiation-induced neoplasms of the unprotected brain, na-
sophanryngeal tract, and upper extremities remain a concern
for high-volume operators (10–12). Additional measures to
reduce operator radiation during radial procedures have
been proposed, such as a tubing extension allowing for
greater distance between the x-ray tube and the operator,
and a special radiation protection board (13,14). Pelvic lead
shielding of the patient has been reported to reduce operator
radiation exposure during femoral access cardiac catheter-
ization, but its effect for radial access has not been investi-
gated (15). In this study, we evaluated the efficacy of a pelvic
lead shield for transradial cardiac catheterization and com-
pared it with the femoral access.
Methods
Study design. Patients sched-
uled for elective, outpatient cor-
onary angiography with an inter-
ventional cardiologist (H.W.L.),
who has extensive experience in
radial access procedures, were
asked to participate in the study. After informed consent
was obtained, the catheterization procedures were randomly
allocated by time period to a femoral or radial approach with
or without the pelvic lead shield in place. After completion
of the procedure, only cases fulfilling the following criteria
were included in the study: the procedure was uncompli-
cated, and the right radial or right femoral artery could be
accessed without difficulties; aortic valve stenosis or bypass
grafts were not present; and aortography was not performed.
If coronary intervention was performed immediately after
the diagnostic procedure, fluoroscopy time and radiation
measurements were recorded before the intervention was
started.
Cardiac catheterization. Procedures were performed on a
digital single-plane cineangiography unit (Integris, Philips
Medical Systems, Best, the Netherlands) with an undertable
x-ray tube. In general, 17.8-cm magnification and a film
speed of 12.5 frames/s was used except for selected views.
For radial procedures, the patient’s right arm was placed on
an arm board with the wrist extended. All cases were done
from the right arm. Radial access was accomplished by
puncture with a 20-gauge needle and insertion of a 5-F
Abbreviation
and Acronym
DAP  dose-area producthydrophilic sheath. Judkins left 3.5, right 4.0, and pigtailcatheters were used initially in radial cases, a Judkins left 4.0
in femoral cases.
Radiation protection. Attention was given in all cases to
one in as much as possible. An overhead-suspended lead
crylic shield with a patient contour cutout (0.5-mm lead
quivalent; MAVIG, Munich, Germany) was pulled down
o the patient’s abdomen. An undertable pivotal leaded side
hield (0.5-mm lead equivalent) was mounted to the side of
he table. The 17.8-cm upper shield flap was folded down
n all cases. An additional table-to-floor flap (0.5-mm
ead equivalent) extended 30 cm along the table. The
elvic lead shield used was a custom-made lead blanket
0.5-mm lead equivalent; MAVIG; list price currently
1,500) measuring 70 90 cm extending from the patient’s
iaphragm to the knees. The upper portion is shaped
iagonally to permit caudal projections. There are 1 or 2
5  15-cm cutouts for the femoral puncture sites (Fig. 1).
Radiation measurements. An electronic Geiger Muller ra-
iation dosimeter (R. A. Stephen 6000, Centronic, Croy-
en, United Kingdom) was used to measure operator
adiation exposure. It was attached to the breast pocket on
he outside of the lead apron. The dosimeter has an energy
esponse 20% between 35 keV and 1.0 MeV and a dose
ange displayed from 0 to 9,999 mSv in steps of 0.0001
Sv  0.1 Sv. The operator radiation dose was recorded
t the beginning and the end of each procedure. The patient
adiation dose, expressed as dose-area product (DAP)
Gy·cm2), and the fluoroscopy time were recorded for each
case. To account for low-energy scatter radiation below 35
keV and other dosimetric effects, the Stephen 6000 dosim-
eter was calibrated with a verified ionization chamber
dosimeter (EG&G Berthold TOL/F, Berthold Technolo-
Figure 1. Pelvic Lead Shield Protecting the Operator From Scatter
Radiation
Scatter source is the triangle between the ceiling-mounted lead acrylic
shield and the undertable pivotal side shield. A 15  15-cm cutout enables
access to the groin. The position of the right wrist is slightly closer to the
x-ray tube than the groin.
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447gies, Bad Wildbad, Germany), which has a reliable energy
response between 10 keV and 7 MeV. Calibration measure-
ments using an Alderson Rando phantom (Radiology Sup-
port Devices, Long Beach, California) at a height of 130 cm
during fluoroscopy revealed that the Stephen 6000 dosim-
eter underestimated the ambient dose equivalent at tissue
depth of 10 mm, that is, H*(10), by a factor of 1.7.
Data analysis. All data are expressed as mean  standard
deviation. Comparisons between groups were done with the
Mann-Whitney U-test and the chi-square test. A p value
0.05 was considered significant. To take into account
differences in patient radiation dose between radial and
femoral cases, the DAP-normalized operator dose (operator
dose divided by the DAP) was calculated.
Results
Of 305 cases scheduled for cardiac catheterization, 210
(69%) fulfilled the inclusion criteria. One hundred seven
cases were done from a radial access, 51 without and 56 with
pelvic lead shielding; 103 cases were done from a femoral
access, 50 without and 53 with pelvic lead shielding.
Analysis of patient characteristics revealed no differences
in age, sex, body surface area, and the prevalence of cases in
whom a left ventriculogram was done in addition to coro-
nary angiography (Table 1).
Fluoroscopy time was higher for the 107 radial cases than
for the 103 femoral cases: 2.7 1.4 min for radial versus 2.1 1.1
min for femoral cases (p  0.001). Fluoroscopy times were
similar when the same access was used. Patient radiation
dose (DAP) was not different when comparing all radial and all
femoral cases (23.2 13.7 vs. 21.9 13.7SvGy1 cm2;
p 0.51), and there were no differences between the groups with
Table 1. Patient Characteristics
Radial Standard
(n  51)
Radial Pelvic Shield
(n  56)
Female 14 (27) 15 (27)
Age, yrs 63 9.3 64.1 9.9
Body surface area, m2 1.9 0.2 2.0 0.2
Left ventriculogram 16 (31) 16 (29)
Values are n (%) and mean SD.
Table 2. Fluoroscopy Time and Radiation Measurements
Radial Standard
(n  51)
Radial Pelvic
(n  56
Fluoroscopy time, min 2.7 1.5 2.7 1.2
DAP*, Gy  cm2 22.5 13.8 23.8 13
Operator radiation dose†, Sv 20.9 13.8 9.0 5.4
DAP-normalized operator radiation dose,
Sv  Gy1  cm2
0.94 0.28 0.39 0.1Values are mean SD. *Dose-area product (DAP); †ambient dose equivalent H*(10), where 10 indicates atandard protection or those with the pelvic shield (Table 2).
perator radiation dose with standard protection was 20.9 13.8
Sv in the radial group and 15.3 10.4Sv in the femoral group
p 0.001). Pelvic lead shielding decreased operator exposure to
.0 5.4 Sv (p 0.0001) in the radial group and to 2.9 2.7
Sv (p  0.0001) in the femoral group. The absolute
reduction in DAP-normalized operator dose (operator dose
in Sv divided by DAP in Gy  cm2) was the same (0.55
nd 0.54) (Fig. 2) for radial and femoral cases (from 0.94 
.28 to 0.39  0.19 Sv  Gy1 cm2 and 0.70 0.26 to
0.16  0.13 Sv  Gy1  cm2, respectively).
We used the SAS procedure General Linear Model (SAS
nstitute, Cary, North Carolina) to analyze the influence of
hield (yes, no), route of access (radial, femoral), and the
nteraction term shield  access on operator radiation dose
nd DAP-normalized operator radiation, respectively. In
oth models, we observed a significant influence of shield
nd route of access, whereas the interaction term shield 
ccess was not significant (p  0.82 and p  0.91 for
perator radiation dose and DAP-normalized operator ra-
iation dose, respectively).
iscussion
Transradial cardiac catheterization is well known to be
associated with an increase in radiation dose to the patient
and the operator, even for highly experienced cardiologists
and despite the use of optimal strategies to reduce radiation
exposure (6–9). The degree of increase in radiation with
radial access varies between operators, suggesting different
measures to protect against radiation exposure (7,8).
Factors responsible for the increased radiation are proce-
dure related and operator related: first, technical challenges
Value
Femoral Standard
(n  50)
Femoral Pelvic Shield
(n  53) p Value
.938 20 (40) 14 (26) 0.143
.958 64.9 11.5 66.2 10.4 0.639
.435 1.9 0.2 1.9 0.2 0.748
.752 14 (28) 13 (25) 0.125
p Value
Femoral Standard
(n  50)
Femoral Pelvic Shield
(n  53) p Value
0.866 2.3 1.2 1.9 1.0 0.047
0.508 23.6 16.0 20.3 12.8 0.323
0.0001 15.3 10.4 2.9 2.7 0.0001
0.0001 0.70 0.26 0.16 0.13 0.0001p
0
0
0
0Shield
)
.6
9depth of 10 mm.
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448in maneuvering the catheters into the coronary ostia lead to
more fluoroscopy time, which will diminish with increasing
expertise of the operator (9). In our study, fluoroscopy time
was only slightly longer (2.7 vs. 2.1 min; p 0.001) without
ncreasing the DAP to a statistically significant degree. The
ncrease in fluoroscopy time and DAP due to the transradial
oute is less for percutaneous coronary intervention com-
ared with diagnostic angiography since catheter position-
ng claims a much smaller portion of the total procedure
6,7). A recent study in 5,954 cases estimated the overall
ncrease in patient radiation exposure due to the radial
pproach at 23% (8). Second and most important for the
eed of improved radiation protection, the closer position of
he operator relative to the x-ray tube is inherent to the
adial procedure. We have previously reported that the
perator dose was doubled for diagnostic procedures and
0% higher for interventions (6).
Exploratory measurements in our laboratory (data on file)
howed profound amounts of scatter radiation from the
elvic bones emerging from the angle between the ceiling-
ounted transparent lead shield positioned at a 90° angle to
he table and the undertable pivotal side shield (Fig. 1),
hich can be nearly abolished by a shield covering the
atient’s pelvis and thighs. Our study proves that the pelvic
ead shield is a highly effective protection device reducing
adiation dose from 20.9 to 9.0 Sv for radial coronary
angiography. Two previous studies investigated additional
ways to improve radiation protection for radial access
catheterization. A 10-mm tube extension of the coronary
catheter failed to reduce operator dose significantly (13).
The “transradial radiation-protection board,” developed by
Hildick-Smith, addresses the same radiation leak of scatter
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Figure 2. Effect of a Pelvic Lead Shield During Cardiac Catheterization
The dose-area product (DAP)-normalized radiation dose of the operator
(Sv· Gy1  cm2) by radial access (left) and femoral access (right).
The amount of reduction is similar for both routes.radiation by mounting a 20-cm-high vertical plane of aleaded shield on the patient’s arm rest. It was found to
reduce radiation dose for diagnostic radial cases from 19 to
12 Sv (14). Comparisons of the efficacy of radiation
protection devices between studies are difficult since dosim-
eters used in their study may have a different dose response.
Based on the data provided, we estimate that the transradial
protection board and the pelvic lead shield have similar
efficacy.
For the assessment of the relative efficacy of an added
radiation protection device, the DAP-normalized operator
dose, defined as the dose (Sv) received by the operator
with each Gy·cm2 applied to the patient, has been advocated
nd was applied in our study (16). We found that the
bsolute reduction by the use of pelvic lead shielding was
imilar for radial and femoral access (0.55 and 0.54 Sv 
Gy1  cm2, respectively). Thus, pelvic lead shielding is
equally effective for the femoral approach, reducing the
radiation dose to as little as 0.16 Sv  Gy1  cm2.
However, when comparing radial and femoral access routes
with optimal radiation protection by pelvic lead shielding, a
radial-access operator still received a markedly higher DAP-
normalized dose (0.39  0.19 Sv  Gy1  cm2) than
femoral-access operator. However, this radiation exposure
as less than that received by a femoral operator without the
enefit of pelvic lead protection (0.70  0.26 Sv  Gy1 
cm2). Looking at our results from a different perspective,
e can conclude that the use of pelvic shielding enables the
perator to perform 4 times more femoral cases and more
han twice as many radial cases with the same radiation
xposure.
Because the use of pelvic lead shielding is associated with
ery little inconvenience to the patient, the operator, or the
aboratory personnel, it has been readily accepted in our
nstitution by femoral operators as well. The lead cover has
Velcro fastener that allows for easy removal with the sterile
raping of the patient intact when tortuous iliac arteries
eed to be visualized or abdominal aortography needs to be
erformed. For percutaneous coronary intervention of
hronic total occlusions, pelvic lead covers with 2 custom-
ade holes for bilateral femoral access are routinely used in
ur institution.
Although pelvic lead shielding is highly effective in
educing radiation, it cannot close the “radiation gap” for
he operator between radial and femoral access. We believe
hat further reductions in radiation exposure for radial
perators are possible and should be aimed for, such as a
ombination of the pelvic lead shield and the protection
oard. These measures may eventually eliminate the differ-
nce in operator radiation exposure associated with the
adial approach, which still exists today.
Study limitations. We only included highly selected proce-
dures, that is, elective uncomplicated diagnostic coronary
angiograms by the same experienced operator. We choose
this study design to be able to analyze uniform and highly
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449comparable cohorts, thus avoiding the need to adjust for
differences in operator experience and procedural factors.
However, the relative efficacy of radiation protection pro-
vided by a pelvic lead shield may be different in an
unselected cohort with different operators and coronary
interventional procedures.
Conclusions
Pelvic lead shielding offers effective radiation protection to
the operator working from a transradial access. The absolute
amount of dose reduction per DAP applied to the patient is
similar for radial and femoral procedures. Despite the use of
the pelvic shield, the operator radiation dose for transradial
diagnostic coronary angiograms remains higher compared
with the femoral route.
Reprint requests and correspondence: Dr. Helmut W. Lange,
Kardiologisch-Angiologische Praxis Herzzentrum Bremen, Sena-
tor Wessling Str. 1A, 28277 Bremen, Germany. E-mail: hwlmd@
mx.de.
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